The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

New research provides further evidence that thrombolysis benefits select patients with acute ischemic stroke up to 24 hours after symptom onset.

RA'ANANA, Israel - Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN), an innovative medical technology company valued at $15.7 million, has announced positive initial results from its collaboration ...

Inspira Technologies OXY B.H.N. announced positive initial results from collaboration with Ennocure MedTech to develop ...

WISeKey’s WISeID Empowers Users with Digital Identity Control in a Geopolitically Uncertain WorldGeneva, Switzerland, ...

The Palestinians of Gaza should not be carried away or misled by the opposition and criticism of practically entire Muslim ...

Daniels says the shortage of brand name drugs like glucagon-like peptide-1 (GLP-1) medications to treat diabetes and obesity ...

The performances of liquid and film-type NIR scintillation detectors based on π-conjugated polymers containing hypervalent tin(IV) compounds ... suggesting their practical use as NIR ...

Baxalta spinoff was successful, Baxter's financial results fell substantially in 2022-23 on external pressures, such as inflation and weak medical utilization trends. With medical utilization rising, ...

Recent research supports the use of 2% chlorhexidine and 70% ... Betadine, an iodine-based solution, has been utilized for IV site cleaning. A study published in the American Journal of Critical ...

Matuszewski, M.S., Pharm.D. Finally, Pendergrast et al. [23] reported the results of IVIG use at four Toronto hospitals from 1995 through 2000. In 429 patients, IVIG use was distributed among the ...

Baxter notified customers on Jan. 22 that allocations for two sodium chloride IV solutions have been increased to 100%. According to Baxter, the products will have a one- to two-week lag time while ...